Jazz Pharmaceuticals (JAZZ) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the conditional marketing ...

M.S.C.E., executive vice president, global head of research and development, and chief medical officer of Jazz Pharmaceuticals. "If approved, zanidatamab would be the first HER2-targeted therapy ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a price target of $59.00. The company’s shares closed ...

Pharmaceutical manufacturing sits at the intersection of science, technology, and global health—driving critical advances in how medicines are developed, produced, and delivered. News Medical ...

GENEVA — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company ...

M.S.C.E., executive vice president, global head of research and development, and chief medical officer of Jazz Pharmaceuticals. "If approved, zanidatamab would be the first HER2-targeted therapy ...

today announces the in-licensing of two clinical-stage oncology programs from Astex Pharmaceuticals ('Astex'), a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd. Mosaic has identified ...

– Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function, 1 also known as HRS-AKI 2 – Abstract #4243460: Treatment and Outcomes of ...

Brad Setser’s testimony to the United States Senate Committee on Finance addresses pharmaceutical manufacturers and U.S. international tax policy. I want to thank Chairman Wyden, Ranking Member ...